Literature DB >> 3276736

Kniest dysplasia is characterized by an apparent abnormal processing of the C-propeptide of type II cartilage collagen resulting in imperfect fibril assembly.

A R Poole1, I Pidoux, A Reiner, L Rosenberg, D Hollister, L Murray, D Rimoin.   

Abstract

Epiphyseal and growth plate cartilages from four cases of Kniest dysplasia have been studied. In each case collagen fibril organization appeared abnormal by electron microscopy compared with age-matched normal cartilages: fibrils were much thinner, of irregular shape and did not exhibit the characteristic banding pattern. This was associated with the absence (compared with normal cartilage) of the C-propeptide of type II collagen (chondrocalcin) from the extracellular matrix of epiphyseal cartilages, although it was detected (as in normal cartilages) in the lower hypertrophic zone of the growth plate in association with calcifying cartilage. The C-propeptide was abnormally concentrated in intracellular vacuolar sites in Kniest cartilages and its total content was reduced in all cases but not in all cartilages. Moreover, it was not a part of the procollagen molecule. In contrast, type II collagen alpha-chain size was normal, indicating the formation of a triple helix. Also type II collagen content was normal and it was present in extracellular sites and only occasionally detected intracellularly. These observations suggest that the defect in Kniest dysplasia may result from the secretion of type II procollagen lacking the C-propeptide and abnormal fibril formation, and that the C-propeptide is normally required for fibril formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276736      PMCID: PMC329606          DOI: 10.1172/JCI113356

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Termination of procollagen chain synthesis by puromycin. Evidence that assembly and secretion require a COOH-terminal extension.

Authors:  J Rosenbloom; R Endo; M Harsch
Journal:  J Biol Chem       Date:  1976-04-10       Impact factor: 5.157

2.  The biosynthesis of collagen and its disorders (second of two parts).

Authors:  D J Prockop; K I Kivirikko; L Tuderman; N A Guzman
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

3.  Immunofluorescent localization of collagen types I, II, and III in the embryonic chick eye.

Authors:  K von der Mark; H von der Mark; R Timpl; R L Trelstad
Journal:  Dev Biol       Date:  1977-08       Impact factor: 3.582

4.  Formation of interchain disulfide bonds and helical structure during biosynthesis of procollagen by embryonic tendon cells.

Authors:  J D Schofield; J Uitto; D J Prockop
Journal:  Biochemistry       Date:  1974-04-23       Impact factor: 3.162

5.  Biosynthesis of cartilage procollagen. Influence of chain association and hydroxylation of prolyl residues on the folding of the polypeptides into the triple-helical conformation.

Authors:  J Uitto; D J Prockop
Journal:  Biochemistry       Date:  1974-10-22       Impact factor: 3.162

6.  A new variety of spondyloepiphyseal dysplasia characterized by punctate corneal dystrophy and abnormal dermal collagen fibrils.

Authors:  P H Byers; K A Holbrook; J G Hall; P Bornstein; J W Chandler
Journal:  Hum Genet       Date:  1978-01-19       Impact factor: 4.132

7.  The Kniest syndrome.

Authors:  C D Siggers; D L Rimoin; J P Dorst; S B Doty; B R Williams; D W Hollister; R Silberberg; R E Cranley; R L Kaufman; V A McKusick
Journal:  Birth Defects Orig Artic Ser       Date:  1974

8.  Procollagen peptidase: an enzyme excising the coordination peptides of procollagen.

Authors:  C M Lapière; A Lenaers; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

9.  Morphologic studies in the skeletal dysplasias.

Authors:  D O Sillence; W A Horton; D L Rimoin
Journal:  Am J Pathol       Date:  1979-09       Impact factor: 4.307

10.  The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin).

Authors:  A Hinek; A Reiner; A R Poole
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

View more
  14 in total

Review 1.  Bone growth mechanisms and the effects of cytotoxic drugs.

Authors:  H Robson
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 2.  Molecular heterogeneity in chondrodysplasias.

Authors:  P H Byers
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

3.  The deletion of six amino acids at the C-terminus of the alpha 1 (II) chain causes overmodification of type II and type XI collagen: further evidence for the association between small deletions in COL2A1 and Kniest dysplasia.

Authors:  A Winterpacht; A Superti-Furga; U Schwarze; H Stöss; B Steinmann; J Spranger; B Zabel
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

4.  Type II achondrogenesis-hypochondrogenesis: identification of abnormal type II collagen.

Authors:  M Godfrey; D W Hollister
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

5.  Of mice and men: heritable skeletal disorders.

Authors:  O Jacenko; B R Olsen; M L Warman
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

6.  Kniest dysplasia is caused by dominant collagen II (COL2A1) mutations: parental somatic mosaicism manifesting as Stickler phenotype and mild spondyloepiphyseal dysplasia.

Authors:  J Spranger; H Menger; S Mundlos; A Winterpacht; B Zabel
Journal:  Pediatr Radiol       Date:  1994

7.  Ocular-chondrodysplasia in labrador retriever dogs: a morphometric and electron microscopical analysis.

Authors:  C E Farnum; K Jones; R Riis; N J Wilsman
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

8.  Expression, in cartilage, of a 7-amino-acid deletion in type II collagen from two unrelated individuals with Kniest dysplasia.

Authors:  R Bogaert; D Wilkin; W R Wilcox; R Lachman; D Rimoin; D H Cohn; D R Eyre
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

9.  SSCP and segregation analysis of the human type X collagen gene (COL10A1) in heritable forms of chondrodysplasia.

Authors:  W A Sweetman; B Rash; B Sykes; P Beighton; J T Hecht; B Zabel; J T Thomas; R Boot-Handford; M E Grant; G A Wallis
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

10.  An RNA-splicing mutation (G+5IVS20) in the type II collagen gene (COL2A1) in a family with spondyloepiphyseal dysplasia congenita.

Authors:  G E Tiller; M A Weis; P A Polumbo; H E Gruber; D L Rimoin; D H Cohn; D R Eyre
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.